Glasheen James Walter

CIK 00015328302 companiesMILL VALLEY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001532830

Recent Transactions

26 trades

Award
SOLENO THERAPEUTICS INC$SLNO
Employee stock option (right to buy)
2018-06-11+15,931→ 15,931 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2018-02-05$1.73/sh+3,962→ 1,419,489 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2017-10-02$0.52/sh+13,154→ 26,945 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2017-07-06$0.61/sh+11,213→ 13,791 total
Award
SOLENO THERAPEUTICS INC$SLNO
Employee stock option (right to buy)
2017-05-08+45,139→ 45,139 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2017-04-07$0.63/sh+2,578→ 2,578 total
Award
SOLENO THERAPEUTICS INC$SLNO
Employee stock option (right to buy)
2017-03-07+20,000→ 20,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-05+8,000→ 8,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2015-05-07+8,000→ 8,000 total
Conversion
Revance Therapeutics, Inc.
Series E-4 Convertible Preferred Stock
2014-02-11−2,801→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-4 Convertible Preferred Stock
2014-02-11−303,563→ 0 total
Exercise of In-Money
Revance Therapeutics, Inc.
Common Stock
2014-02-11+149→ 16,852 total
Conversion
Revance Therapeutics, Inc.
Common Stock
2014-02-11+622,648→ 622,648 total
Exercise of In-Money
Revance Therapeutics, Inc.
Common Stock
2014-02-11+52,087→ 709,162 total
Conversion
Revance Therapeutics, Inc.
Series E-5 Convertible Preferred Stock
2014-02-11−89,186→ 0 total
Conversion
Revance Therapeutics, Inc.
Convertible Promissory Notes
2014-02-11−34,427→ 0 total
Exercise of In-Money
Revance Therapeutics, Inc.
Warrant to Purchase Common Stock
2014-02-11−52,087→ 0 total
Exercise of In-Money
Revance Therapeutics, Inc.
Warrant to Purchase Common Stock
2014-02-11−149→ 0 total
Conversion
Revance Therapeutics, Inc.
Common Stock
2014-02-11+16,703→ 16,703 total
Conversion
Revance Therapeutics, Inc.
Common Stock
2014-02-11+34,427→ 657,075 total
Conversion
Revance Therapeutics, Inc.
Series E-1 Convertible Preferred Stock
2014-02-11−5,231→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-1 Convertible Preferred Stock
2014-02-11−81,959→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-2 Convertible Preferred Stock
2014-02-11−4,125→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-2 Convertible Preferred Stock
2014-02-11−73,275→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-3 Convertible Preferred Stock
2014-02-11−4,546→ 0 total
Conversion
Revance Therapeutics, Inc.
Series E-3 Convertible Preferred Stock
2014-02-11−74,665→ 0 total

Companies

Recent Filings

Address

C/O TECHNOLOGY PARTNERS 100 SHORELINE HWY, BLDG B, STE 282

MILL VALLEY, CA, 94941

View on SEC.gov